CRISPRとCas遺伝子の世界市場、2033年までの機会と戦略

世界のCRISPRとCas遺伝子市場は2018年に12億9,736万米ドルと評価され、2023年まで20.0％以上のCAGRで成長しました。

個別化医療への関心の高まり

個別化医療への関心の高まりがCRISPRとCas遺伝子市場の成長を促進しました。個別化医療は、精密医療や個別化医療とも呼ばれ、患者一人ひとりの特性に合わせた治療や介入を目指す医療へのアプローチです。個別化医療は、個人の遺伝子プロファイルに合わせた治療に焦点を当てた、精密な遺伝子治療の需要を促進します。CRISPR技術は、このような変異に対処するための標的遺伝子編集を可能にし、CRISPRに基づく治療への投資の増加につながった。このため、ヘルスケアにおける遺伝性疾患やがんなどの治療への導入が加速しています。例えば、科学者、患者、医療提供者を代表し、患者とヘルスケアシステムに利益をもたらす個別化医療の理解と導入を促進する米国の組織である個別化医療連合（Personalized Medicine Coalition）によると、2022年10月には、複数のタイプのがん、遺伝的希少疾患、さまざまな慢性疾患や感染症の患者向けに、75,000を超える遺伝子検査製品と300の個別化医薬品が市場に出回っていました。さらに、個別化医薬品は2022年に米国食品医薬品局が承認した新薬の34％を占め、過去8年間はいずれも承認の25％以上を占めています。したがって、個別化医療への関心の高まりが、歴史的な期間におけるCRISPRとCas遺伝子市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

• CRISPRとCas遺伝子-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

• 一般的な市場の定義
• 概要
• CRISPRとCas遺伝子市場定義とセグメンテーション
• 市場セグメンテーション：タイプ別
  • 製品
  • サービス
• 市場セグメンテーション：用途別
  • ゲノム工学
  • 疾患モデル研究
  • 機能ゲノミクス
  • エピジェネティクス
  • その他の用途
• 市場セグメンテーション：最終用途別
  • バイオテクノロジーおよび製薬会社
  • 学術機関および政府調査機関
  • 契約調査機関（CRO）

第7章 主要な市場動向

• 高度な遺伝子編集ツールが精密な遺伝子改変を通じて個別化医療に革命を起こす
• 遺伝子編集アプリケーションにおけるコスト削減と精度向上を実現する最先端ツール
• 主要企業間の戦略的パートナーシップとコラボレーションにより製品ラインナップを強化
• 精密医療と先進バイオ製造を強化する統合調査イニシアチブ
• 革新的なCRISPRアプローチによる遺伝性疾患の治療、第1相臨床試験で有望な結果

第8章 CRISPRとCas遺伝子市場- マクロ経済シナリオ

• COVID-19の影響： CRISPRとCas遺伝子市場
• ウクライナ戦争の影響： CRISPRとCas遺伝子市場
• 高インフレの影響： CRISPRとCas遺伝子市場

第9章 世界の市場規模と成長

• 市場規模
• 市場成長実績, 2018-2023
  • 市場促進要因2018-2023
  • 市場抑制要因2018-2023
• 市場成長予測, 2023-2028, 2033F
  • 市場促進要因2023-2028
  • 市場抑制要因2023-2028

第10章 世界のCRISPRとCas遺伝子市場：セグメンテーション

• 世界のCRISPRとCas遺伝子市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のCRISPRとCas遺伝子市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のCRISPRとCas遺伝子市場：最終用途別、実績と予測, 2018-2023, 2028F, 2033F

第11章 CRISPRとCas遺伝子市場：地域・国別分析

• 世界のCRISPRとCas遺伝子市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のCRISPRとCas遺伝子市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

• 企業プロファイル
• Danaher Corporation
• Agilent Technologies Inc
• CRISPR Therapeutics AG
• Beam Therapeutics Inc
• Merck Co. & KGaA

第20章 その他の大手企業と革新的企業

• Regeneron Pharmaceuticals Inc
• GenScript Biotech Corporation
• Editas Medicine Inc
• Synthego Corp
• Takara Bio Inc
• Intellia Therapeutics Inc
• Caribou Biosciences Inc
• Poseida Therapeutic Inc
• Mammoth Biosciences Inc
• Metagenomi
• Locus Biosciences Inc
• KSQ Therapeutics Inc
• New England BioLabs Inc
• Inscripta Inc
• Epic Bio

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

• Arbor Biotechnologies Acquired Serendipity Biosciences
• Cellistic Acquired Artisan Bio'S CRISPR Intellectual Property Asset
• EditCo Bio Acquired Synthego's Engineered Cell Solutions Business
• Ensoma Acquired Twelve Bio
• Intellia Therapeutics Acquired Rewrite Therapeutics

第24章 機会と戦略

• 世界のCRISPRとCas遺伝子市場2028：新たな機会を提供する国
• 世界のCRISPRとCas遺伝子市場2028：新たな機会を提供するセグメント
• 世界のCRISPRとCas遺伝子市場2028：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第25章 CRISPRとCas遺伝子市場：結論と提言

• 結論
• 提言
  • 製品
  • 場所
  • 価格
  • プロモーション
  • 人

第26章 付録

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) genes form part of a bacterial immune system that protects against viruses and foreign genetic elements. CRISPR refers to sequences of deoxyribonucleic acid (DNA) that contain short, repetitive segments, which bacteria use to store snippets of viral DNA after an infection. If the bacteria encounter the same virus again, they can recognize it based on these stored sequences. Cas genes encode proteins (like Cas9) that act as molecular scissors. These proteins can cut DNA at specific sites guided by RNA molecules (gRNA), which are transcribed from the CRISPR sequences. This mechanism allows precise gene editing and has revolutionized genetic research, enabling scientists to alter DNA in plants, animals and humans with high accuracy.

The CRISPR and Cas gene market consists of sales, by entities (organizations, sole traders and partnerships), of gene-editing tools and technologies used for precise DNA modifications.

The global CRISPR and CAS gene market was valued at $1,297.36 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.0%.

Growing Interest In Personalized Medicine

Growing interest in personalized medicine propelled the growth of the CRISPR and CAS gene market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Personalized medicine drives demand for precise genetic therapies, focusing on treatments tailored to an individual's genetic profile. CRISPR technology enables targeted gene editing to address these variations, leading to increased investment in CRISPR-based therapies. This has accelerated its adoption for treating genetic disorders, cancer and other conditions in healthcare. For instance, in October 2022, according to the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, more than 75,000 genetic testing products and 300 personalized medicines were present on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, growing interest in personalized medicine supported the growth of the CRISPR and CAS gene market during the historic period.

Advanced Gene Editing Tools To Revolutionize Personalized Medicine Through Precise Genetic Modifications

Major companies in the CRISPR and Cas gene market are focusing on developing advanced gene editing tools to enhance personalized medicine through precise genetic modifications. These tools enable targeted treatments tailored to an individual's genetic profile, addressing conditions like genetic disorders, cancer and rare diseases. By modifying specific genes responsible for disease progression, CRISPR technologies offer more effective therapies, improving patient outcomes and minimizing risks compared to traditional treatments, marking a significant advancement in precision medicine. For example, in May 2024, Profluent, a US-based AI-first protein design company, released the sequence of OpenCRISPR-1, a novel Cas9 gene editor with improved off-target editing created through Profluent's artificial intelligence (AI), using large language model trained on a database of 5.1 million Cas9-like proteins. This open-source project has the potential to revolutionize CRISPR treatment options by leveraging AI to develop new gene-editing reagents, marking a significant step forward in precision medicine.

The global CRISPR and Cas gene market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 70.11% of the total market in 2023.

CRISPR And Cas Gene Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global CRISPR and Cas gene market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for CRISPR and Cas gene? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The CRISPR and Cas gene market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider CRISPR and Cas gene market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application, by product type, by end use and by service type.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the CRISPR and Cas gene market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application, by product type, by end use and by service type in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for CRISPR and Cas gene providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Products; Services
• 2) By Application: Genome Engineering; Disease Model Studies; Functional Genomics; Epigenetics; Other Applications
• 3) By Product Type: Kits And Enzymes; Libraries; Design Tool; Antibodies; Other Products
• 4) By End Use: Biotechnology And Pharmaceutical Companies; Academics And Government Research Institutes; Contract Research Organizations (CROs)
• 5) By Service Type: Cell Line Engineering, Grna Design, Microbial Gene Editing; DNA Synthesis
• Companies Mentioned: Danaher Corporation; Agilent Technologies Inc.; CRISPR Therapeutics Inc.; Beam Therapeutics Inc.; Merck Co. & KGaA.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; CRISPR and Cas gene indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 CRISPR And Cas Gene - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 CRISPR And Cas Gene Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Products
  • 6.4.2 Services
• 6.5 Market Segmentation By Application
  • 6.5.1 Genome Engineering
  • 6.5.2 Disease Model Studies
  • 6.5.3 Functional Genomics
  • 6.5.4 Epigenetics
  • 6.5.5 Other Applications
• 6.6 Market Segmentation By End Use
  • 6.6.1 Biotechnology And Pharmaceutical Companies
  • 6.6.2 Academics And Government Research Institutes
  • 6.6.3 Contract Research Organizations (CROs)

7 Major Market Trends

• 7.1 Advanced Gene Editing Tools To Revolutionize Personalized Medicine Through Precise Genetic Modifications
• 7.2 Cutting-Edge Tools Reducing Costs And Improving Accuracy In Gene Editing Applications
• 7.3 Strategic Partnerships And Collaborations Among Major Players To Enhance Product Offerings
• 7.4 Unified Research Initiatives Enhancing Precision Medicine And Advanced Biomanufacturing
• 7.5 Innovative CRISPR Approaches To Treating Genetic Disorders With Promising Phase 1 Clinical Trial Results

8 CRISPR And Cas Gene Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The CRISPR And Cas Gene Market
• 8.2 Impact Of The War In Ukraine On The CRISPR And Cas Gene Market
• 8.3 Impact Of High Inflation On The CRISPR And Cas Gene Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global CRISPR And Cas Gene Market Segmentation

• 10.1 Global CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.1.1 Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.1.2 Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 CRISPR And Cas Gene Market, Regional and Country Analysis

• 11.1 Global CRISPR And Cas Gene Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global CRISPR And Cas Gene Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific CRISPR And Cas Gene Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe CRISPR And Cas Gene Market: Country Analysis
• 13.6 UK Market
• 13.7 UK CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe CRISPR And Cas Gene Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America CRISPR And Cas Gene Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America CRISPR And Cas Gene Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Investments
  • 18.2.11 Major Companies
• 18.3 Africa CRISPR And Cas Gene Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa CRISPR And Cas Gene Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa CRISPR And Cas Gene Market, Segmentation By End Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Danaher Corporation
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Agilent Technologies Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 CRISPR Therapeutics AG
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Beam Therapeutics Inc
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Financial Overview
• 19.6 Merck Co. & KGaA
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 CRISPR And Cas Gene Market Other Major And Innovative Companies

• 20.1 Regeneron Pharmaceuticals Inc
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 GenScript Biotech Corporation
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Editas Medicine Inc
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Synthego Corp
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Takara Bio Inc
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Intellia Therapeutics Inc
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Caribou Biosciences Inc
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Poseida Therapeutic Inc
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Mammoth Biosciences Inc
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Metagenomi
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Locus Biosciences Inc
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 KSQ Therapeutics Inc
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 New England BioLabs Inc
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Inscripta Inc
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Epic Bio
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Arbor Biotechnologies Acquired Serendipity Biosciences
• 23.2 Cellistic Acquired Artisan Bio' S CRISPR Intellectual Property Asset
• 23.3 EditCo Bio Acquired Synthego's Engineered Cell Solutions Business
• 23.4 Ensoma Acquired Twelve Bio
• 23.5 Intellia Therapeutics Acquired Rewrite Therapeutics

24 Opportunities And Strategies

• 24.1 Global CRISPR And Cas Gene Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global CRISPR And Cas Gene Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global CRISPR And Cas Gene Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 CRISPR And Cas Gene Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer